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Type III Secretion in the Melioidosis
Pathogen Burkholderia pseudomallei
Charles W. Vander Broek and Joanne M. Stevens*
The Roslin Institute and Royal (Dick) School of Veterinary Studies, University of Edinburgh, Midlothian, United Kingdom
Burkholderia pseudomallei is a Gram-negative intracellular pathogen and the causative
agent of melioidosis, a severe disease of both humans and animals. Melioidosis is an
emerging disease which is predicted to be vastly under-reported. Type III Secretion
Systems (T3SSs) are critical virulence factors in Gram negative pathogens of plants
and animals. The genome of B. pseudomallei encodes three T3SSs. T3SS-1 and -2, of
which little is known, are homologous to Hrp2 secretion systems of the plant pathogens
Ralstonia and Xanthomonas. T3SS-3 is better characterized and is homologous to the
Inv/Mxi-Spa secretion systems of Salmonella spp. and Shigella flexneri, respectively.
Upon entry into the host cell, B. pseudomallei requires T3SS-3 for efficient escape from
the endosome. T3SS-3 is also required for full virulence in both hamster and murine
models of infection. The regulatory cascade which controls T3SS-3 expression and
the secretome of T3SS-3 have been described, as well as the effect of mutations of
some of the structural proteins. Yet only a few effector proteins have been functionally
characterized to date and very little work has been carried out to understand the hierarchy
of assembly, secretion and temporal regulation of T3SS-3. This review aims to frame
current knowledge of B. pseudomallei T3SSs in the context of other well characterized
model T3SSs, particularly those of Salmonella and Shigella.
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INTRODUCTION
Bacteria are required to adapt to and survive in constantly changing and harsh environments. In
order to respond to and alter their environment, secretion systems have evolved in bacteria to
export proteins into the surrounding milieu (reviewed in Costa et al., 2015). One secretion system
in Gram-negative bacteria that has been the focus of much research in the last three decades is
the Type III secretion system (T3SS) (reviewed in Galán et al., 2014). Type III Secretion Systems
(T3SSs) have been shown to be important for virulence inmany Gram-negative bacterial pathogens
of animals and plants; including Pseudomonas syringae, Xanthomonas, Ralstonia solanacearum,
Erwinia, pathogenic Escherichia coli, Salmonella, Shigella, Yersinia, and Burkholderia (Gemski et al.,
1980; Maurelli et al., 1985; Galán and Curtiss, 1989; Jarvis et al., 1995; Stevens et al., 2002; Büttner
and He, 2009). T3SSs span the bacterial inner and outer membranes forming a “molecular syringe”
which allows bacteria to export proteins, called effectors, from the bacterial cytoplasm into a target
eukaryotic cell (reviewed in Galán et al., 2014).
The focus of this review is T3SSs in the pathogenic bacterium Burkholderia pseudomallei, and
to some extent the closely related species B. mallei and B. thailandensis. Originally described in
drug addicts in Rangoon in the early twentieth century by Alfred Whitmore (Whitmore, 1913),
Burkholderia pseudomallei is a facultative intracellular pathogen (Pruksachartvuthi et al., 1990)
Vander Broek and Stevens Type III Secretion in Burkholderia pseudomallei
that is the causative agent of melioidosis, or Whitmore’s disease.
Melioidosis is a severe disease of humans and animals, causing
an estimated 165,000 cases of human melioidosis per year
resulting in a predicted 89,000 deaths (Limmathurotsakul et al.,
2016). Infection with B. pseudomallei is usually associated with
environmental exposure and can occur through breaks in the
skin, inhalation or ingestion (reviewed in Cheng and Currie,
2005). In the majority of cases, the incubation period for
melioidosis is between 1 and 21 days following infection (Ngauy
et al., 2005). About 50% of melioidosis cases affect people with
diabetes and other important risk factors include lung disease,
cystic fibrosis and excessive alcohol consumption (Currie et al.,
2010). There are varied clinical presentations of B. pseudomallei
infection ranging from skin infections to pneumonia and septic
shock, which hampers accurate diagnosis in a clinical setting
(Currie et al., 2010). B. pseudomallei is reported to be able to
reactivate after remaining latent following a primary infection.
The longest reported period between infection and reactivation
occurred in aWorldWar II veteranwhomanifested symptoms 62
years after exposure (Ngauy et al., 2005). B. pseudomallei has been
classified as a bioterrorism agent by both the UK government and
the US Centres for Disease Control and Prevention (reviewed in
Rotz et al., 2002; Cheng and Currie, 2005).
B. mallei, the causative agent of glanders in horses and
other solipeds, is a zoonotic pathogen with restricted host range
(Yabuuchi et al., 1992; Srinivasan et al., 2001). In humans,
B. mallei causes a disease similar to melioidosis and has been
similarly classified as a potential bioterrorism agent in the UK
and US (Rotz et al., 2002; Van Zandt et al., 2013). The soil
saprophyte B. thailandensis is non-pathogenic and present in
high numbers in the soils and standing waters of endemic areas.
This species is commonly used as an alternative model system for
B. pseudomallei and B. mallei studies as its genome encodes many
homologs of virulence factors from these pathogenic species
(Brett et al., 1998; Moore et al., 2004; Yu et al., 2006; Haraga et al.,
2008).
TYPE THREE SECRETION SYSTEMS IN
B. PSEUDOMALLEI
The B. pseudomallei genome encodes three T3SSs which are
referred to as T3SS-1, T3SS-2, and T3SS-3. The genome of
B. pseudomallei consists of two circular chromosomes, with
all three T3SSs residing on chromosome 2 (Holden et al.,
2004). T3SS-2 and T3SS-3 are present in the genomes of B.
mallei and B. thailandensis, whereas T3SS-1 is absent from both
(Rainbow et al., 2002). T3SS-1 and T3SS-2 are relatively poorly
characterized and share homology with the Hrp2 family of T3SSs
found in plant pathogens (Winstanley et al., 1999; Rainbow et al.,
2002). The best characterized of the B. pseudomallei T3SSs, T3SS-
3, is also known as the Burkholderia secretion apparatus (Bsa)
T3SS. It is a member of the Inv-Mxi-Spa family of T3SSs from
Salmonella spp. (SPI-1) and Shigella flexneri (Attree and Attree,
2001; Stevens et al., 2002; Egan et al., 2014).
Burkholderia pseudomallei T3SS-1 (BPSS1390-BPSS1410) and
T3SS-2 (BPSS1610-BPSS1629) show closest homology to the
Hrp2 T3SS of the plant pathogen Ralstonia solanacearum (Angus
et al., 2014). B. pseudomallei T3SS-2 expression is activated
by the AraC-type regulator HrpB (BPSS1610) (Lipscomb and
Schell, 2011). HrpB also regulates the expression of a type IV
pilus encoded directly upstream of T3SS-2, but does not appear
to regulate the other T3SSs in B. pseudomallei (Lipscomb and
Schell, 2011). In order to investigate the role that T3SS-1 and
T3SS-2 play in plants, a tomato plant infection model was
established for B. pseudomallei and B. thailandensis (Lee et al.,
2010). B. pseudomallei KHW T3SS-1 and T3SS-2 mutants were
reported to be attenuated in tomato plants (Lee et al., 2010).
However, in a more recent study, B. thailandensis did not display
phytopathogenic activity in tomato plants which were treated
identically to those in Lee et al. (2010), Lipscomb and Schell
(2011). The question of whether B. pseudomallei is capable of
infecting plants, and what if any role T3SS-1 and -2 have in this
process, remain important unanswered questions.
The function of T3SS-1 and -2 in mammalian systems has
also been investigated to some extent. T3SSs-1 and -2 do not
appear to be required for vacuole escape of the bacterium into the
cytoplasm of infected macrophages (Burtnick et al., 2008), and
are dispensable in a Syrian hamster model of infection (Warawa
and Woods, 2005). However, a B. pseudomallei T3SS-1 mutant
displayed increased co-localisation with the autophagy marker
LC3 and a reduction in intracellular survival in RAW264.7 cells
(D’Cruze et al., 2011). In the same study, T3SS-1 was required
for full virulence in a respiratory murine model of melioidosis
(D’Cruze et al., 2011). Both earlier studies inactivated T3SS-
1 by mutating the structural auto-protease component (BpscU,
Table 1) (Warawa and Woods, 2005; Burtnick et al., 2008) while
the latter study generated a system knockout by mutation of the
ATPase (BpscN, Table 1), which may account for the different
phenotypes observed.
T3SS-3
The best characterized of the three T3SSs, T3SS-3 (BPSS1516-
BPSS1552, Figure 1) is a member of the Inv/Mxi-Spa family of
T3SSs (Egan et al., 2014) of which the prototypic systems are
found in Salmonella Spp. and Shigella flexneri. The Salmonella
and Shigella prototypic systems are required in these bacteria
for host cell invasion and escape from the endocytic vacuole
into the cytosol, respectively (reviewed in Galán et al., 2014). B.
pseudomallei is a facultative intracellular pathogen capable of
survival in both phagocytic and non-phagocytic cell lines (Jones
et al., 1996). T3SS-3 is required for B. pseudomallei to efficiently
escape the endocytic vesicle (Stevens et al., 2002). The T3SS-3
is also required for full virulence in both murine and Syrian
hamster models of infection (Stevens et al., 2004; Warawa and
Woods, 2005; Gutierrez et al., 2015a). T3SS-3 deficient mutants
are also impaired in their ability to disseminate from the lungs
of mice infected intra-nasally (Gutierrez et al., 2015a). A recent
study used Tn-seq to identify genes required for respiratory
melioidosis in mice and identified the following T3SS-3
genes as being required: bprA (BPSS1530), bipC (BPSS1531),
bipB (BPSS1532), bicA (BPSS1533), bsaZ (BPSS1534), bsaW
(BPSS1537), bsaV (BPSS1538), bsaO (BPSS1545), bsaM
(BPSS1547), bsaL (BPSS1548), bsaK (BPSS1549), and bsaJ
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TABLE 1 | B. pseudomallei T3SS-1 and -2 genes, corresponding proteins and predicted functions.
B. pseudomallei K96243 B. pseudomallei K96243 R. solanacearum Universal Nomenclature Predicted function
T3SS-1 T3SS-2 Hrp2 Protein name
Locus tag Protein name Locus tag Protein name Protein name
BPSS1388 Similar to Hrpk1
from P. syringae
Translocator
BPSS1390 BpscC BPSS1592 BpscC2 HrcC SctC Outer membrane ring / secretin
BPSS1391 BpspB BPSS1610 BpspB2 HrpB T3SS Regulator
BPSS1392 BpscT BPSS1629 BpscT2 HrcT SctT Inner membrane export apparatus
BPSS1393 BpspD BPSS1628 BpspD2 HrpD SctO Stalk protein
BPSS1394 BpscN BPSS1627 BpscN2 HrcN SctN ATPase
BPSS1395 BpscL BPSS1626 BpscL2 HrcL SctL Stator protein
BPSS1396 BpspH BPSS1625 BpspH2 HrpH Inner membrane component
BPSS1397 BpscJ BPSS1624 BpscJ2 HrcJ SctJ Inner membrane ring component
BPSS1398 BpspJ BPSS1623 BpspJ2 HrpJ Inner rod component
BPSS1399 BpspK BPSS1622 BpspK2 HrpK Inner rod component
BPSS1400 BpscU BPSS1621 BpscU2 HrcU SctU Autoprotease, early/middle substrate switch
BPSS1401 BpscV BPSS1620 BpscV2 HrcV SctV Export gate
BPSS1402 BpsaP BPSS1619 BpsaP2 HpaP SctP Regulates needle length / translocator secretion
BPSS1403 BpscQ BPSS1618 BpscQ2 HrcQ SctQ Cytoplasmic ring
BPSS1404 BpscR BPSS1617 BpscR2 HrcR SctR Inner membrane export apparatus
BPSS1405 BpscS BPSS1616 BpscS2 HrcS SctS Inner membrane export apparatus
BPSS1406 BpspV BPSS1615 BpspV2 HrpV Secreted regulator
BPSS1407 BpscD BPSS1614 BpscD2 HrcD SctD Inner membrane ring component
BPSS1410 BpsaB BPSS1611 BpsaB2 HpaB Chaperone
Homologs from R. solanacearum Hrp2 T3SS are given for reference. Where applicable, the universal nomenclature for T3SS structural proteins is also listed to allow for comparison to
genes from T3SS-3 listed in Table 2.
(BPSS1550) (Gutierrez et al., 2015b). This highlights the
importance of T3SS-3 in melioidosis.
TRANSCRIPTIONAL REGULATION OF
T3SS-3
The transcriptional regulation of T3SS-3 has been elucidated
(Sun et al., 2010). At the top of the regulatory hierarchy is the gene
bspR (BPSL1105), which, when disrupted led to a reduced level of
expression of genes in the T3SS-3 locus as shown by microarray
and real time PCR (Sun et al., 2010). bspR signals through the
membrane bound regulator bprP (BPSS1553) which controls
expression levels of both structural and secreted components
of T3SS-3 (Sun et al., 2010). bprP further signals through bsaN
(BPSS1546) and its co-activator, the chaperone bicA (BPSS1533),
controlling transcription of the known effectors bopC, bopE
and bopA, as well as the chaperone bicP (BPSS1523) and the
regulators bprB-D (BPSS1520-22) (Sun et al., 2010; Chen et al.,
2014). bsaN also relays the regulation signal to the virulence-
associated Type 6 secretion system and virulence factors such as
bimA and virAG (Sun et al., 2010; Chen et al., 2014).
The presence of genes allowing for arabinose assimilation was
one of the first methods used to differentiate between virulent B.
pseudomallei and avirulent B. thailandensis (Smith et al., 1997;
Moore et al., 2004). Expressing the B. thailandensis arabinose
assimilation operon in B. pseudomallei causes a down-regulation
of expression of the T3SS-3 genes, notably the T3SS regulator
bsaN, and also results in a reduction in virulence in a Syrian
hamster model of infection (Moore et al., 2004). This suggests
that loss of the arabinose assimilation operon may account for
some of the differential virulence observed between these two
species of Burkholderia (Moore et al., 2004).
STRUCTURE OF T3SS-3
The structure of the T3SS is well conserved and is similar to
that of the bacterial flagella system (Kubori et al., 1998; Young
et al., 1999; Gophna et al., 2003). It is thought that the flagella
and the T3SS evolved from a similar ancestor, but the T3SS has
been the product of a large amount of horizontal gene transfer
(Gophna et al., 2003). T3SSs are separated into seven different
families named after the archetype system in each family, each
with slight differences in structure and host cell target, with
multiple types of T3SS present in some bacterial species (e.g.,
plant or animal) (reviewed by Büttner, 2012). In recent years the
structure of the Salmonella T3SS has been solved using cryo-EM
(Schraidt andMarlovits, 2011) and cryo-ET (Hu et al., 2017). The
structure of the Salmonella T3SS (reviewed by Galán et al., 2014)
consists of inner and outer membrane rings connected by a rod,
the extracellular needle and a secreted translocation pore which
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FIGURE 1 | B. pseudomallei K96243 T3SS-3 gene locus. Also known as the bsa locus, the T3SS-3 genes are encoded by chromosome 2 (BPSS1516-BPSS1554).
Arrows which point right represent genes encoded on the forward strand and arrows which point left represent genes encoded on the reverse strand. Gene locus tags
are listed below each arrow and gene names are listed above. The arrows are color coded according to their predicted function.
spans the target cell membrane. Assembly of the T3SS appears
to be hierarchical and is the subject of multiple recent reviews
(Büttner, 2012; Diepold and Wagner, 2014). Based on evidence
fromYersinia and Salmonella, it appears construction of the T3SS
begins with the formation of the outer-membrane/structural
ring (Secretin) and independently the inner membrane export
machinery, which are then linked by YscJ (Yersinia) or PrgK
(Salmonella), followed by assembly of the ATPase/C-ring and
the formation of the mature needle complex (Diepold et al.,
2010, 2011; Wagner et al., 2010). The structural proteins in
the B. pseudomallei T3SS-3 (Figure 2) that have been studied
specifically are described below.
Components of the Export Apparatus
BsaZ (BPSS1534)
BsaZ (BPSS1534) is a structural component with homology to
SpaS of Salmonella (Stevens et al., 2002). SpaS is a component
of the export apparatus and has been shown to undergo
auto-cleavage causing a switch between secretion of structural
components (early substrates) to secretion of the needle complex
and translocator proteins (intermediate substrates) (Zarivach
et al., 2008). B. pseudomallei bsaZ mutants are unable to
secrete effector and translocator proteins (Stevens et al., 2003;
Muangman et al., 2011; Vander Broek et al., 2015). Mutations in
bsaZ result in a significant delay in escape from the phagosome
and reduced intracellular survival in J774.2 cells (Stevens et al.,
2002; Burtnick et al., 2008). bsaZ mutants are also attenuated in
murine (Stevens et al., 2004; Burtnick et al., 2008) and Syrian
hamster (Warawa andWoods, 2005) models of melioidosis. bsaZ
mutants have proven to be a useful tool in understanding the
role of T3SS-3 in B. pseudomallei pathogenesis, however, the
effect of these mutations other than an inability to secrete effector
proteins is not well understood. For example, it is unclear if BsaZ
undergoes auto-cleavage and is involved in secretion hierarchy in
a similar manner to SpaS. It has also not been determined if bsaZ
mutants still assemble the external needle appendage, or at what
stage in formation of themature T3SS complex they are impaired.
BsaQ (BPSS1543)
Another component of the export apparatus of the
B. pseudomallei T3SS-3 that has been described is BsaQ
(BPSS1543), which is homologous to InvA from Salmonella (Sun
et al., 2005). InvA is required for the formation of the mature
T3SS in Salmonella as well as secretion of effector proteins
(Kubori et al., 2000). bsaQ mutants display a similar phenotype
to other T3SS-3 structural mutants in that they are delayed in
phagosome escape, resulting in reduced intracellular survival
(Muangsombut et al., 2008). The bsaQ mutants are unable to
secrete the effector protein BopE or translocator tip protein BipD,
and show significant defects in cell invasion (Muangsombut
et al., 2008). Similarly to BsaZ, there is a gap in our knowledge of
whether BsaQ truly functions in a manner similar to InvA.
Inner Membrane Ring
BsaM (BPSS1547)
The inner membrane component BsaM (BPSS1547) is
homologous to Salmonella PrgH, which forms the inner
membrane ring of the Salmonella T3SS and is required for
secretion of effector proteins (Kubori et al., 2000; Marlovits
et al., 2004). A B. pseudomallei bsaM mutant induced lower
levels of NF-κB signaling in HEK 293T cells when compared to
the isogenic parent strain (Teh et al., 2014). The bsaM mutant
activated NF-κB at time points corresponding to a delayed escape
from the phagosome, suggesting it has similar effects to the other
T3SS-3 structural knockouts (Teh et al., 2014).
Needle Components
BsaL (BPSS1548)
A crystal structure of the protein BsaL (BPSS1548) demonstrated
significant structural similarity with MxiH (Shigella) and PrgI
(Salmonella), which form the external needle structure (major
needle subunit) of the T3SS (Zhang et al., 2006; Wang et al., 2007;
Barrett et al., 2008). BsaL is recognized by the host cell neuronal
inhibitory protein (NAIP) leading to activation of the NLRC4
inflammasome (Yang et al., 2013). NLRC4 has been shown to
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FIGURE 2 | The predicted structure of the B. pseudomallei K96243 T3SS-3 based on Salmonella SPI-1. The name of the protein which is predicted to constitute
each structural component, as well as colors to represent different portions of the T3SS structure, are shown. (A) Before host cell contact, the T3SS is fully assembled
spanning both the inner and outer bacterial membrane. The needle forms a channel extending out of the bacterium which is capped by the needle tip protein.
(B) After contact with the host cell, a signal is relayed through the T3SS and translocator proteins form a pore in the host cell membrane allowing for injection of
bacterial effector proteins.
be important in a murine model of respiratory melioidosis and
a human NLRC4 polymorphism is associated with survival in
melioidosis patients (West et al., 2014).
BsaK (BPSS1549)
The cellular protein Nod-like receptor NLRC4 recognizes
T3SS minor needle component proteins from a range of
Gram-negative bacteria, including BsaK (BPSS1549) from B.
pseudomallei, activating an innate immune response through
casapase-1 (Miao et al., 2010; Zhao et al., 2011; Bast et al., 2014).
A B. pseudomallei bsaK mutant was highly attenuated in an
intranasal murine model of melioidosis (Bast et al., 2014).
Non-structural Proteins
BsaU (BPSS1539)
BsaU (BPSS1539) is homologous to InvJ from Salmonella which
is the “molecular ruler” which determines the length of the T3SS
needle (Kubori et al., 2000). Mutation of bsaU in B. pseudomallei
resulted in delay in phagosome escape and reduced virulence in
a BALB/c intranasal mouse infection model (Pilatz et al., 2006).
The mutant was also deficient in its ability to secrete the effector
protein BopE and the translocator tip protein BipD (Pilatz et al.,
2006). It can be hypothesized that without BsaU, the needle
complex of T3SS-3 forms incorrectly, accounting for the lack of
effector and translocator secretion.
BsaP (BPSS1544)
A family of T3SS proteins called the “gatekeeper” proteins
(InvE/MxiC/SepL/YopN-TyeA) are involved in the control
of effector and translocator protein secretion and the
switch from intermediate to late substrates for secretion in
Salmonella/Shigella/E. coli/Yersinia, respectively (reviewed in
Büttner, 2012). These proteins are involved in the temporal
regulation of their respective T3SSs and deletion of all of these
proteins causes an increase in levels of secreted effectors, but has
differing effects on the secretion of translocators. For example
deletion of invE (Kubori and Galán, 2002) and sepL (Kresse et al.,
2000; Deng et al., 2004, 2005) causes a reduction in translocator
secretion, deletion of mxiC (Botteaux et al., 2009) has no effect
on translocator secretion, and deletion of yopN (Forsberg et al.,
1991; Iriarte et al., 1998) increases levels of secreted translocators.
The closest homolog to this family of proteins in B. pseudomallei
is BsaP (BPSS1544), which we have demonstrated functions as
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a gatekeeper protein for effectors in a manner most similar to
Salmonella invE (Vander Broek et al., 2015). Deletion of bsaP
creates a phenotype in which effector proteins are hyper-secreted
with a concomitant decrease in translocator secretion (Vander
Broek et al., 2015). Further studies are warranted to determine
the molecular interactions of BsaP with other components of the
T3SS-3, in order to fully understand BsaP in the context of the
other members of the gatekeeper family of proteins.
Structural Components for Which No Data
Is Available
Proteins for which no published work is available are OrgA
(BPSS1551), OrgB (BPSS1552), BsaJ (BPSS1550), BsaO
(BPSS1545), BsaT (BPSS1540), BsaV (BPSS1538), BsaW
(BPSS1537), BsaX (BPSS1536), and BsaY (BPSS1535). The
putative function of these proteins can be found in Table 2 and
their predicted location in the structure of T3SS-3 is shown in
Figure 2.
T3SS-3 has been well studied in terms of its role in virulence
however very little has been reported on the structure and
the molecular interactions between individual components of
the T3SS itself. Determining the finer points of structure and
hierarchy of assembly represent a major unanswered research
question in terms of understanding T3SS-3 in the context of other
well studied T3SSs.
ENERGIZING SECRETION AND
UNFOLDING OF SUBSTRATES
Proteins are secreted in an unfolded state due to the narrowwidth
of the needle channel which is 2–3 nm in S. flexneri (Blocker et al.,
2001; Radics et al., 2014). This was proven by cryo-EM imaging
of a substrate which was engineered to become trapped in the
secretion channel (Radics et al., 2014). The ATPase at the base of
the secretion system has been shown to dissociate proteins from
their chaperones and is also thought to be involved in unfolding
of the protein (Akeda and Galán, 2005). The source of energy for
exporting proteins is the subject of some debate. In the flagellar
T3SS of Yersinia and Salmonella, secretion can take place in the
absence of the ATPase (Wilharm et al., 2004; Erhardt et al., 2014).
This evidence, combined with a study which showed flagellar
T3S was halted in the absence of a proton gradient, has led to
the hypothesis that the ATPase is primarily required for protein
unfolding and that proton motive force energizes secretion of the
unfolded substrate (Paul et al., 2008).
The B. pseudomallei T3SS-3 ATPase is BsaS (BPSS1541). A
B. pseudomallei bsaS mutant was unable to secrete the known
effector protein BopE, demonstrated a defect in intracellular
survival in RAW264.7 cells and was attenuated in BALB/c mice
infected intra-nasally, demonstrating that the ATPase is required
for T3S of effector proteins and has a similar phenotype to other
T3SS-3 structural mutants (Gong et al., 2015). This agrees with
a previous study in which B. pseudomallei and B. thailandensis
containing in-frame deletions in bsaS, were impaired in their
ability to escape the endosomal compartment and form plaques
in host cell monolayers as a result of cell-to-cell spread (French
et al., 2011). Salmonella lacking a functional ATPase will still
assemble a mature T3SS, and will still secrete effector proteins,
though at a reduced level (Erhardt et al., 2014). The effect that
a bsaS mutation in B. pseudomallei T3SS-3 may have on either
assembly of the T3SS apparatus or the secretion of early/middle
substrates, such as the major needle component (BsaL) and the
needle tip protein (BipD) remains an interesting open question.
NEEDLE TIP AND TRANSLOCATOR
PROTEINS-SENSING HOST CONTACT
Upon host cell contact, the translocators of the T3SS are inserted
into the host cell membrane forming a pore through which
effector proteins may pass. Shigella is able to lyse red blood
cells by inserting the translocators IpaB and IpaC into the
RBC membrane forming a 25 angstrom pore (Blocker et al.,
1999). Secretion of the translocator proteins is controlled by the
needle tip protein. A Shigella needle tip protein mutant (ipaD),
constitutively secreted the translocators IpaB and IpaC (Picking
et al., 2005). Immunofluorescence microscopy demonstrated
the presence of the Shigella IpaD protein on the surface
of the bacteria in the absence of a host cell membrane, a
finding that was further confirmed by electron microscopy
(Espina et al., 2006). The needle tip protein probably acts
to sense host cell contact, inhibiting premature secretion of
translocators (Espina et al., 2006). In the same study it was
shown that antibodies to the tip protein disrupted the haemolysis
of sheep erythrocytes indicating the functional importance
of IpaD in the insertion of the translocator complex into
eukaryotic cell membranes, as well as regulating effector protein
secretion (Espina et al., 2006). Next, the T3SS senses host
cell contact when IpaD binds to bile salts causing IpaB to be
exposed at the needle tip (Olive et al., 2007; Stensrud et al.,
2008).
The final step in secretion of the translocation pore is
dependent on Shigella interacting with host cell lipids to induce
IpaC secretion (Epler et al., 2009). When cultured in the presence
of liposomes, IpaC localizes to the bacterial surface and is
secreted (Epler et al., 2009). This agrees with earlier evidence that
cholesterol is bound by translocation components (Salmonella
SipB and Shigella IpaB), is important for entry into host cells and
is required for efficient translocation of effector proteins into host
cells (Lafont et al., 2002; Hayward et al., 2005). There is some
evidence to suggest that the translocator proteins, along with the
needle tip and a functional T3SS, may be sufficient to determine
the intracellular niche of Salmonella and Shigella in the absence
of any of the effector proteins (Du et al., 2016).
BipD (BPSS1529)
BipD (BPSS1529) is the needle tip protein of the B. pseudomallei
T3SS-3. It is homologous to SipD (Salmonella), IpaD (Shigella),
and LcrV (Yersinia). BipD has been confirmed to be secreted
by the B. pseudomallei T3SS-3 (Stevens et al., 2003; Vander
Broek et al., 2015). The crystal structure of BipD was solved
(Erskine et al., 2006; Knight et al., 2006; Roversi et al., 2006;
Johnson et al., 2007; Pal et al., 2010) and the 3-dimensional
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TABLE 2 | B. pseudomallei T3SS-3 genes, corresponding proteins and predicted functions.
B. pseudomallei K96243 Homologs Universal nomenclature Function
T3SS-3 Salmonella SPI-1 Shigella Protein name
Locus tag Protein name Protein name Protein name
BPSS1516 BopC Effector
BPSS1517 — Chaperone of BopC
BPSS1518 —
BPSS1519 —
BPSS1520 BprC Regulator of T6SS-1
BPSS1521 BprD Effector/Regulator
BPSS1522 BprB Putative regulator
BPSS1523 BicP SicP Chaperone, shown to bind to BapA
BPSS1524 BopA SptP IcsB Effector protein
BPSS1525 BopE SopE Effector protein
BPSS1526 BapC IagB IpgF Effector protein
BPSS1527 BapB IacP Negative regulator, predicted chaperone
BPSS1528 BapA Effector protein
BPSS1529 BipD SipD IpaD SctA Needle tip
BPSS1530 BprA Putative regulator
BPSS1531 BipC SipC IpaC SctB Minor translocator
BPSS1532 BipB SipB IpaB SctE Major translocator
BPSS1533 BicA SicA IpgC Chaperone/Co-activator of BsaN
BPSS1534 BsaZ SpaS Spa40 SctU Autoprotease, early/middle substrate switch
BPSS1535 BsaY SpaR Spa29 SctT Inner membrane export apparatus
BPSS1536 BsaX SpaQ Spa9 SctS Inner membrane export apparatus
BPSS1537 BsaW SpaP Spa24 SctR Inner membrane export apparatus
BPSS1538 BsaV SpaO Spa33 SctQ Cytoplasmic ring
BPSS1539 BsaU InvJ Spa32 SctP Needle length control protein
BPSS1540 BsaT InvI Spa13 SctO Stalk protein
BPSS1541 BsaS InvC Spa47 SctN ATPase
BPSS1542 BsaR InvB Spa15 Chaperone, predicted to bind BopE
BPSS1543 BsaQ InvA MxiA SctV Export gate
BPSS1544 BsaP InvE MxiC SctW Middle/late substrate switch
BPSS1545 BsaO InvG MxiD SctC Outer membrane ring / secretin
BPSS1546 BsaN InvF MxiE Regulator of T3SS-3 effector proteins
BPSS1547 BsaM PrgH MxiG SctD Inner membrane ring component
BPSS1548 BsaL PrgI MxiH SctF Outer rod/ major needle component
BPSS1549 BsaK PrgJ MxiI SctI Inner rod/minor needle component
BPSS1550 BsaJ PrgK MxiJ SctJ Inner membrane ring component
BPSS1551 OrgA OrgA MxiK SctK ATPase cofactor
BPSS1552 OrgB OrgB MxiN SctL Stator protein
BPSS1553 BprP Regulator of T3SS-3
BPSS1554 BprQ Regulator of T3SS-3
Homologs from Salmonella SPI-1 and Shigella are given for reference. Where applicable, the universal nomenclature for T3SS structural proteins is also listed.
structure is highly similar to IpaD of Shigella (Johnson et al.,
2007) and Salmonella SipD (Espina et al., 2007), but bipD
cannot functionally complement sipD in Salmonella (Klein et al.,
2017). It was demonstrated that the structure of BipD, as well
as IpaD and SipD, is dependent on pH changes (Markham
et al., 2008). Interestingly when cultured in a more acidic
pH of 4.5, B. thailandensis secretes increased amounts of
BipD as well as BopE (Jitprasutwit et al., 2010), though the
study also described amino acid differences between BipD of
B. pseudomallei and B. thailandensis (Jitprasutwit et al., 2010),
raising the question as to what effect pH may have on T3SS-3 in
B. pseudomallei.
In a B. pseudomallei bipD mutant, the levels of both
translocators and effectors secreted into the culture supernatant
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are increased (Stevens et al., 2003; Vander Broek et al., 2015),
in agreement with data published for the homologous Shigella
protein IpaD (Parsot et al., 1995; Picking et al., 2005). IpaD
blocks secretion of effector proteins until host cell contact has
taken place (Roehrich et al., 2013), and because of its similarity
in both sequence and structure (Erskine et al., 2006) it is
perhaps unsurprising that BipD would function in a similar
manner. More recent evidence suggests that Shigella IpaDmay be
involved in controlling the secretion of translocator and effector
proteins through an interaction with the gatekeeper protein
MxiC (Roehrich et al., 2016). This would suggest an interaction
between BipD and BsaP in B. pseudomallei which may have a
similar activity.
Needle tip proteins are of particular interest because of their
potential use as subunit vaccines. Most notably the Yersinia pestis
needle tip protein LcrV (V antigen), especially when combined
with the Fraction 1 (F1) protein, is an effective vaccine that has
been tested in human clinical trials (reviewed by Williamson,
2009). Vaccination of mice with the Shigella needle tip protein
IpaD, along with the translocator IpaB, induced high levels of
protection upon subsequent challenge (Martinez-Becerra et al.,
2012, 2013; Heine et al., 2013). Some 15 years ago, it was
described that convalescent serum from a melioidosis patient
reacted specifically with a recombinant GST-tagged BipD protein
(Stevens et al., 2002). CD4+ T cells taken from mice infected
with an attenuated strain of B. pseudomallei showed specificity
for BipD (Haque et al., 2006). Similarly, human monocyte-
derived dendritic cells from healthy B. pseudomallei seropositive
donors were pulsed with purified BipD after which CD4+ T
cells were able to recognize the recombinant protein (Tippayawat
et al., 2011). A B. pseudomallei bipD mutant was significantly
attenuated in a BALB/c intranasal murine infection model,
demonstrating the importance of this protein in vivo (Stevens
et al., 2004). Attempts have been made to use BipD as a
recombinant subunit vaccine in a BALB/c murine intraperitoneal
model of infection, but in both studies the vaccine showed no
protection upon subsequent challenge (Stevens et al., 2004; Druar
et al., 2008).
BipB (BPSS1532)
BipB (BPSS1532) shares 46% amino acid identity with the
Salmonella translocator protein SipB, and is secreted by T3SS-
3 in a bsaZ dependant manner (Vander Broek et al., 2015). In
a Salmonella sipB mutant, bipB is unable to complement sipB
demonstrating evolutionary separation of these proteins (Klein
et al., 2017). This is an important reminder that although T3SSs
are similar in structure, T3SS proteins do not always function
identically.
A B. pseudomallei K96243 bipB insertion mutant showed
reduced invasion and cell-to-cell spread in HeLa cells, and a
reduced ability to form multi-nucleated giant cells in J774 cells
(Suparak et al., 2005). In vivo, in BALB/c mice infected intra-
nasally, the bipB mutant was greatly attenuated and showed
a phenotype similar to that of the bipD translocator mutant
(Stevens et al., 2004; Suparak et al., 2005). This is likely due to the
inability of the T3SS to function correctly without the formation
of the translocation pore, and any proposed secondary function
would require further investigation. The N-terminal region of
BipB has been tested as a protective antigen in a murine model
of melioidosis, but as with BipD, showed no protection upon
subsequent challenge (Druar et al., 2008).
BipC (BPSS1521)
BipC (BPSS1531) is a homolog of the Salmonella SipC and
Shigella IpaC translocator proteins. The Salmonella SipC protein
has been shown to interact with SipB to form the translocon
pore (Myeni et al., 2013). Beyond their role as a translocator
protein, SipC and IpaC also function as effector proteins within
the eukaryotic cell. SipC has actin nucleation activity and bundles
F-actin (Hayward and Koronakis, 1999). The ability of SipC to
nucleate and bundle F-actin as well as form the translocation
pore, are all dependant on the C-terminal 209 amino acids of the
409 amino acid protein (Hayward and Koronakis, 1999; Chang
et al., 2005; Myeni and Zhou, 2010). Actin bundling appears
to be important for cell invasion, as Salmonella containing a
sipC mutation abolishing its actin bundling activity, but not
translocator function, was less invasive than the parental strain
(Myeni and Zhou, 2010). Internalization of B. pseudomallei can
be blocked by the actin polymerization inhibitor cytochalasin D
(Jones et al., 1996), indicating the importance of actin cytoskeletal
rearrangements in the uptake of B. pseudomallei. Similarly to
SipC, BipC is also able to polymerise actin in vitro and stabilizes
F-actin indicating possible actin bundling activity (Kang et al.,
2016a and our own unpublished observations). Interestingly,
Salmonella SipA protein enhances the ability of SipC to nucleate
and bundle F-actin (McGhie et al., 2001), but a homolog of
SipA is not encoded by the genome of B. pseudomallei. SipC has
also been shown to bind to host Syntaxin 6 and thereby recruit
LAMP1 to the Salmonella containing vacuole (SCV), helping
to stabilize its membrane (Madan et al., 2012). The functional
relevance of the actin-binding activity of BipC and whether it
binds any other host cell proteins requires further study.
In Salmonella and Shigella, the SipC/IpaC family of
translocator/effector proteins may play a crucial role in
determining the intracellular niche of the bacteria. There is
evidence to suggest that sipC and ipaC cannot fully complement
each other (Osiecki et al., 2001; Klein et al., 2017). The authors
suggest the proteins, while both translocators, may have some
divergent functions which may parallel the different intracellular
lifestyles of the pathogens, with Salmonella residing within the
vacuole and Shigella rapidly escaping into the cytosol (Osiecki
et al., 2001). This is supported by a recent study in which
Salmonella expressing ipaC, was shown to be capable of vacuole
escape (Du et al., 2016). Because of closer parallels between the
intracellular lifestyles of B. pseudomallei and Shigella, we would
predict that BipC would function in a manner more similar to
IpaC than SipC, mediating the exit of the bacterium from the
endocytic compartment into the host cell cytosol. In a Salmonella
sipC mutant, bipC is unable to complement sipC (Klein et al.,
2017), further supporting a possible difference in accessory
function of these proteins.
The C-terminal and N-terminal regions of BipC have
previously been separately tested as a protective antigen in mice,
but neither antigen showed any protection upon challenge with
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B. pseudomallei (Druar et al., 2008). In another study, a B.
pseudomallei bipC mutant showed reduced cell adhesion and
invasion of A549 cells (Kang et al., 2015). This bipC mutant
also showed a delay in escape from the phagosome, leading to
a delay in formation of actin tails in the host cell cytoplasm
and intracellular replication (Kang et al., 2015). The mutant was
also attenuated in BALB/c mice infected intraperitoneally (Kang
et al., 2015). The transcriptome of livers of mice infected with
the bipC mutant showed a lower expression of genes involved in
actin cytoskeleton signaling, MAPK signaling, integrin signaling
and TNF when compared to mice infected with the parental
B. pseudomallei strain (Kang et al., 2016b). While this shows the
importance of BipC in virulence, both in vivo and in vitro, it does
not separate the role of BipC as a translocator necessary for a
functional T3SS and rapid escape from the endosome, from its
role as an effector protein.
SECRETION SIGNALS AND CHAPERONES
Type III secretion signals are located at the N-terminus of a
protein, are not cleaved and do not share primary sequence
identity with each other (Michiels and Cornelis, 1991; Schesser
et al., 1996). In Yersinia, it was demonstrated that as little
as 15 amino acids of the N-terminus of YopE were required
for secretion (Sory et al., 1995). Interestingly, substituting the
alanines at position 2 and 15 in the YopE secretion signal
with glutamic acid, did not affect secretion (Anderson and
Schneewind, 1997). Even shifting the reading frame did not
prevent the secretion of YopE, which the authors suggested may
indicate a secretion signal located in the mRNA encoding the
effector protein (Anderson and Schneewind, 1997).
A second important signal in the N-terminal region of T3SS
effector proteins is the chaperone binding domain (CBD) which
is required for the specific secretion of effector proteins (Abe
et al., 1999; Ehrbar et al., 2003, 2006; Lee and Galán, 2003, 2004)
as well as for their stability in the bacterial cytoplasm (Frithz-
Lindsten et al., 1995; Abe et al., 1999). By determining the crystal
structure of an effector protein bound to its chaperone, it is
known that T3SS chaperones in Yersinia and Salmonella bind
the N-terminal amino acids of their effector protein, just after
the T3S signal, but before any functional domains, and maintain
the bound effector protein in a partially unfolded state that may
be more competent for secretion (Birtalan and Ghosh, 2001;
Stebbins and Galán, 2001).
The T3S signal also appears to be promiscuous between
systems, allowing secretion of effector proteins from bacteria in
an unrelated host bacterium containing a T3SS (Rossier et al.,
1999; Hovis et al., 2013). This is even true of less similar
T3SSs, as demonstrated by the ability of the Hrp Plant T3SS of
Xanthomonas to secrete the mammalian effector protein Yersinia
YopE (Rossier et al., 1999). Perhaps because of the similarity
between the two, virulence-associated T3SS effectors can be
secreted by the bacterial flagellar T3SS system in Yersinia and
Salmonella (Young and Young, 2002; Lee and Galán, 2004;
Warren and Young, 2005; Ehrbar et al., 2006). It is only through
interaction with the appropriate chaperone that specific secretion
through a single system is achieved. Inhibition of the ability of
Salmonella SopE to bind its chaperone InvB, caused secretion
through both the flagellar and SPI-1 virulence associated T3SS
(Lee and Galán, 2004; Ehrbar et al., 2006). The genome of B.
pseudomallei encodes five putative T3SS-3 chaperones, though
little work concerning their function has yet been described.
BPSS1517
The protein encoded by the gene BPSS1517 is predicted to be a
putative chaperone (Panina et al., 2005) and has been shown to
interact with the downstream effector protein BopC (BPSS1516)
(Muangman et al., 2011).
BicP (BPSS1523)
BicP (BPSS1523) shares homology with Salmonella SicP, a specific
chaperone for the effector protein SptP (Fu andGalán, 1998). The
closest homolog to SptP in B. pseudomallei is BopA (BPSS1524)
which was predicted to be the binding partner for BicP (Panina
et al., 2005), but the interaction between the two proteins has not
formally been demonstrated.
BapB (BPSS1526)
BapB (BPSS1526) is homologous to Salmonella IacP (Stevens
et al., 2002). IacP is important for Salmonella invasion into
host cells by playing a role in regulating SopA, SopB and SopD
secretion (Kim et al., 2011). Formerly considered a possible
candidate effector protein, BapB was not found to be secreted by
T3SS-3 (Treerat et al., 2015; Vander Broek et al., 2015). Deletion
of bapB caused an increase in the transcription and secretion
of BopE, indicating it may be a negative regulator of effector
transcription (Treerat et al., 2015). In the same study the authors
performed a phylogenetic analysis which suggested that BapB
may be closely related to the Salmonella FliT chaperone protein
(Treerat et al., 2015).
BicA (BPSS1533)
BicA (BPSS1533) is homologous to the Salmonella chaperone
SicA. SicA binds to and prevents the association and resulting
degradation of SipC and SipB in the bacterial cytoplasm (Tucker
and Galán, 2000). As SipC is secreted by a mature needle
complex, SicA is freed and interacts with the transcriptional
regulator InvF to increase the expression of effector proteins
(Tucker and Galán, 2000; Darwin and Miller, 2001). B.
pseudomallei BicA is required for the secretion of the known
effector proteins BopE and BopA (Sun et al., 2010), and BicA
along with the regulator BsaN activate transcription of T3SS-
3 effector proteins, translocators and chaperones (Chen et al.,
2014). The bicA gene is also able to partially complement a
Salmonella sicA mutant (Klein et al., 2017), further supporting
a homologous function. BicA is required for respiratory
melioidosis in mice (Gutierrez et al., 2015b).
BsaR (BPSS1542)
BsaR (BPSS1542) is homologous to the Salmonella chaperone
InvB which has been shown to be required for secretion of the
effector proteins SopE and SopA (Ehrbar et al., 2003, 2004; Lee
and Galán, 2003). BsaR is predicted to be the chaperone for BopE
using a computational screen for chaperones in B. pseudomallei
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K96243 (Panina et al., 2005), although this has not yet been
experimentally validated.
T3SS-3 EFFECTOR PROTEINS
The role of the T3SS is to deliver an array of effector proteins
into the target cell to subvert host cell functions. The function
of different effector proteins is extremely varied, ranging from
blocking apoptosis (E. coli NleH) (Hemrajani et al., 2010),
prevention of phagocytosis (Yersinia YopH) (Persson et al.,
1997), cytotoxic activity (Pseudomonas aeruginosa ExoU) (Sato
et al., 2003) and disruption of the actin cytoskeleton (Salmonella
SopE) (Hardt et al., 1998). B. pseudomallei encodes seven effector
proteins known to be secreted by T3SS-3 (CHBP, BopC, BopA,
BapA, BprD, BapC, and BopE), as well as one hypothetical T3SS
effector BopB (Pumirat et al., 2014; Vander Broek et al., 2015).
CHBP/Cif (BPSS1385)
CHBP (BPSS1385) is a homolog of E. coli cell cycle inhibiting
factor (Cif) and is the only identified T3SS-3 effector protein that
is encoded outside of the T3SS-3 locus. Cif and CHBP are able to
deamidate cellular NEDD8 causing cell cycle arrest (Nougayrède
et al., 2001; Cui et al., 2010) and CHBP causes cell cycle arrest
when expressed in B. thailandensis (Cui et al., 2010). CHBP has
also been shown to activate the cellular kinase ERK independent
of its ability to deamidate NEDD8 (Ng et al., 2017).
The gene encoding CHBP is present in ∼76% of the available
B. pseudomallei genomes and a Western blot assay used to probe
for the presence of the CHBP protein in B. pseudomallei clinical
isolates from the endemic region detected CHBP in 47% of
isolates tested (Pumirat et al., 2014). Interestingly, CHBP is not
secreted under standard growth conditions, but B. pseudomallei
secretes CHBP in U937 cells in a bsaQ–dependent manner
(Pumirat et al., 2014). A B. pseudomallei K96243 chbP insertion
mutant was impaired in its ability to form plaques in HeLa cells
at 24 h and demonstrated lower cytotoxicity at 6 h as assessed
by LDH release assays (Pumirat et al., 2014). Both phenotypes
could be complemented by expression of chbP in trans indicating
that these phenotypes were due to disruption of the chbP gene
and not due to unexpected polar effects of the insertion mutation
(Pumirat et al., 2014).
BopB/FolE (BPSS1514)
BopB (BPSS1514) or FolE, is annotated to be a GTP
cyclohydrolase I and was thought to be a candidate effector
protein (Stevens et al., 2004). Yet a bopBmutant did not display a
significantly reduced time to death in a BALB/c intraperitoneal
infection model (Stevens et al., 2004). Similarly, mutation of
bopB did not affect invasion and intracellular replication of host
cells (Chen et al., 2014). Expression of bopB is co-regulated with
the other T3SS-3 effectors by BsaN, but the role BopB plays in
infection is still unknown (Chen et al., 2014).
BopC (BPSS1516)
BopC (BPSS1516) is a 509 amino acid protein with no significant
sequence homology to proteins from other species besides B.
mallei. It is encoded just before the T3SS-3 locus along with
BPSS1517, its chaperone (Muangman et al., 2011). BopC was
detected in the culture supernatants of WT B. pseudomallei
10276, but not in supernatants of a bsaZ insertion mutant,
indicating that BopC is secreted by T3SS-3 (Muangman et al.,
2011; Vander Broek et al., 2015). The first 20 amino acids
of BopC fused to the β-lactamase gene TEM1, was sufficient
for translocation into HeLa cells in a T3SS-dependant manner
(Muangman et al., 2011). A B. pseudomalleiK96243 bopCmutant
was hindered in its ability to invade A549 cells (Muangman
et al., 2011) and displayed reduced levels of intracellular survival
(Srinon et al., 2013). The bopCmutant also demonstrated delayed
phagosome escape in J774A.1 cells as shown by staining for co-
localisation of the bacteria with the cellular lysosomal marker
protein LAMP–1, which likely explains the defect in intracellular
survival (Srinon et al., 2013).
BprD (BPSS1521)
BprD (BPSS1521) has no known homology to proteins outside
of B. pseudomallei and the closely related Burkholderia species. It
is labeled as a putative regulator of T3SS-3, though a knockout
of the bpr operon (bprB-D) showed no effect on the expression
of T3SS-3 genes (Sun et al., 2010). Its expression is regulated
by BsaN along with the known effector proteins BopA, BopC
and BopE (Sun et al., 2010; Chen et al., 2014) and bipD gene
expression is significantly up-regulated in tissues of infected mice
(Chirakul et al., 2014). The same study demonstrated attenuation
of the bprD mutant in BALB/c mice infected intraperitoneally,
which the authors speculate may be due to the up-regulation of
the T6SS-1 through effects on bprC (Chirakul et al., 2014).
Our own work has demonstrated that BprD is secreted into
the supernatant in a T3SS-3 bsaZ-dependant manner (Vander
Broek et al., 2015). While this may seem surprising, it is not
without precedent that a regulator of the T3SS is also a substrate
for secretion, for example, Yersinia LcrQ (Cambronne et al.,
2000). It is thought that LcrQ acts as a feedback inhibitor of
the expression of Yersinia effectors (Cambronne et al., 2000).
When LcrQ is secreted into host cells and the levels of LcrQ in
the bacterium are depleted, inhibition is relieved and T3S can
progress (Cambronne et al., 2000). Whether BprD is secreted
into host cells, whether it acts as a true effector protein and
the mechanisms by which it regulates virulence and T6S present
interesting research questions for the field.
BopA (BPSS1524)
BopA (BPSS1524) shares 23% amino acid identity with Shigella
IcsB (Cullinane et al., 2008). It has been predicted to contain
a Rho GTPase inactivation domain (RID) similar to that found
in Vibrio cholerae VcRtxA and other MARTX toxins which
indirectly inactivate Rho GTPases (Pei and Grishin, 2009). IcsB,
along with its chaperone IpgA, are important for Shigella’s ability
to escape LC3-positive autophagosomes once inside the host cell,
and this activity is dependent on the IcsB cholesterol-binding
domain (Kayath et al., 2010; Campbell-Valois et al., 2015). BopA
also contains a functional cholesterol-binding domain (Kayath
et al., 2010). The B. pseudomallei homolog of IpgA is BicP,
which co-purifies with BopA and helps to prevent its degradation,
indicating that it is the chaperone for BopA (Kayath et al., 2010).
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BopA is secreted by T3SS-3 in a bsaZ-dependant manner (Vander
Broek et al., 2015) and the first 58 amino acids of B. mallei BopA
fused to the Yersinia enterolitica phospholipase YplA, has been
shown to be secreted in a surrogate enteropathogenic E. coli host
(Whitlock et al., 2008).
BopA is important for the intracellular survival of B.
pseudomallei in phagocytic cells (Cullinane et al., 2008).
A B. pseudomallei K96243 bopA mutant displayed reduced
intracellular survival and an increased localisation with GFP-
LC3, an indicator of autophagy stimulation, in RAW 264.7 cells
(Cullinane et al., 2008). This reduction in intracellular survival
was overcome when cells were treated with the autophagy
inhibitor wortmannin (Cullinane et al., 2008). Another study
demonstrated that BopA is important for escape of the bacterium
from the phagosome (Gong et al., 2011). A B. mallei ATCC
23344 bopA mutant demonstrated reduced intracellular survival
in J774A.1 cells (Whitlock et al., 2008). Interestingly, in the
murine alveolar macrophage cell line MH-S, the same B.
mallei bopA mutant exhibited increased intracellular survival
when compared to the isogenic parental strain, indicating that
different cell types may rely on different mechanisms to control
intracellular B. mallei (Whitlock et al., 2009). BALB/c mice
infected intraperitoneally with a B. pseudomallei 576 bopA
insertionmutant were significantly delayed in time to death when
compared to the parental strain (Stevens et al., 2004). Similarly,
BALB/c mice infected intra-nasally with a B. mallei ATCC 23344
bopA insertion mutant also showed a delayed time to death. No
bacteria were recovered from the lung tissue of animals infected
with the bopAmutant while 108 bacteria were recovered from the
lungs of animals infected with B. mallei (Whitlock et al., 2009). In
mice immunized with recombinant BopA and challenged intra-
nasally with B. mallei ATCC23344 or B. pseudomallei 1026b, the
BopA vaccine protected 100 and 60%, respectively of animals 21
days post infection (Whitlock et al., 2010).
BopE (BPSS1525)
BopE (BPSS1525) is the best characterized of the B. pseudomallei
effector proteins and is commonly used as a readout for
the ability of the T3SS-3 to secrete effector proteins. BopE
is 27% identical over a region of 168 amino acids to the
Salmonella guanine nucleotide exchange factor (GEF) SopE
(Stevens et al., 2003). BopE is secreted by B. pseudomallei
in a manner dependent on the T3SS-3 (Stevens et al., 2003;
Muangsombut et al., 2008; Vander Broek et al., 2015) and is
required for efficient invasion of non-phagocytic cells (Stevens
et al., 2003). Also, ectopic expression of BopE in HeLa cells causes
significant actin cytoskeletal rearrangements with similarity to
ectopic SipC expression (Stevens et al., 2003). Using fluorescence
spectrometry, it was demonstrated that purified BopE, similar
to SopE, is a functional GEF for both Rac1 and Cdc42, but
with about 10 fold lower activity than SopE (Stevens et al.,
2003). This lower activity may be explained by differences in
the catalytic domains, as the SopE catalytic domain stays in an
open conformation, while BopE adopts a closed conformation
which requires interaction with Cdc42 to allow for GEF activity
(Upadhyay et al., 2008). HEK 293T cells transfected with
plasmids expressing BopE and caspase–1, resulted in increased
activation of caspase–1 and –7 (Bast et al., 2014). When the active
site of the transfected BopE was mutated, levels of activation of
caspase–1 and –7 returned to basal levels indicating BopE’s GEF
activity is required for the activation of caspase–1 and –7 (Bast
et al., 2014).
BopE is a potent T cell antigen inmice (Haque et al., 2006) and
in sero-positive recoveredmelioidosis patients (Tippayawat et al.,
2009). However, in an intraperitoneal BALB/c murine model of
melioidosis, ablation of the bopE gene did not affect the median
time to death of the animals when compared to the parental strain
(Stevens et al., 2004).
BapC (BPSS1527)
BapC (BPSS1526) is homologous to Salmonella IagB (Stevens
et al., 2002). IagB is thought to be a lytic transglycosylase involved
in the breakdown of the bacterial peptidoglycan layer, allowing
connection of the inner and outer membrane components of
the secretion system, though this function has not been formally
demonstrated (Zahrl et al., 2005). BapC is secreted by T3SS-
3 in a manner dependant on bsaS (Treerat et al., 2015). A
B. pseudomalleiK96243 bapCmutant showed a slight attenuation
in a competitive growth assay in an acute BALB/c model of
infection (Treerat et al., 2015), whereas a B. pseudomallei 1026b
bapC mutant showed no significant attenuation in a Syrian
hamster model of melioidosis (Warawa and Woods, 2005).
BapA (BPSS1528)
BapA (BPSS1528) has no known homology to any other
bacterial or host cell proteins except the BapA orthologues of
B. pseudomallei and the closely related species B. thailandensis
and B. mallei. BapA is secreted by T3SS-3 in both a BsaS and
BsaZ dependant manner (Treerat et al., 2015; Vander Broek
et al., 2015). A 1026b B. pseudomallei bapA mutant showed no
attenuation in a Syrian hamster model of infection (Warawa and
Woods, 2005), whereas a B. pseudomallei K96243 bapA mutant
was attenuated in a competitive growth assay in an acute BALB/c
model of infection (Treerat et al., 2015).
FUTURE PERSPECTIVES
While there has been a wealth of new information concerning
B. pseudomallei T3S, there are still many significant gaps in
knowledge, particularly with regard to the importance of T3SS-1
and T3SS-2 in melioidosis. It is possible that the plant pathogen-
like T3SS-1 and T3SS-2 add fitness to B. pseudomallei in the
environment, allowing infection/colonization of adjacent plant
life. However, it is also possible that these systems are relevant
in mammalian hosts, given their conservation amongst the B.
pseudomallei strains sequenced to date, and the finding that
T3SS-1 is required for full virulence in a murine model of
melioidosis (D’Cruze et al., 2011).
It is still unclear whether T3SS-3 plays a significant role in
invasion of host cells, particularly non-phagocytic cells. There
have been many reports of T3SS-3 or its effector proteins playing
a role in invasion (Stevens et al., 2003; Suparak et al., 2005;
Muangsombut et al., 2008; Muangman et al., 2011; Kang et al.,
2015). Yet in another study, T3SS-3 ATPase (bsaS) mutants did
not show a decrease in invasion efficiency in HEK293 or HeLa
cells (French et al., 2011). This observation is important because
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it questions the involvement of T3SS-3 in invasion as well as
highlighting a general lack of understanding of the pathways and
mechanisms involved in B. pseudomallei entry into host cells.
To date CHBP is the only effector protein secreted by the
B. pseudomallei T3SS-3 that is encoded outside of the T3SS-
3 locus, and which is not present in the genome of all strains
(Pumirat et al., 2014). This raises the question of whether other
effector proteins secreted by T3SS-3, but encoded outside of
the T3SS-3 locus, may be present in other strains. Full genome
comparisons of almost 100 strains of B. pseudomallei identified
86% of genes as being conserved and present in all strains (Sim
et al., 2008). The other 14% of genes, considered accessory genes,
were disproportionally present in genomic islands and were
associated with clinical isolates (Sim et al., 2008). The GIs in
B. pseudomallei are highly variable between strains. A study of
five clinical B. pseudomallei strains identified a total of 71 GIs
distributed between the strains, with at least half being unique
to the strain in which they were identified (Tuanyok et al., 2008).
The variability in these regions is largely due to horizontal gene
transfer and B. pseudomallei has a relatively high rate of lateral
gene transfer compared to the mutation rates of other bacterial
species (Pearson et al., 2009). As B. pseudomallei has a large
amount of genomic diversity in its accessory genome and a
high rate of lateral gene transfer, there is a strong possibility
that other novel effector proteins are encoded in other strains
of B. pseudomallei that have yet to be identified. Study of these
effector proteins could provide important insights into strain
differences as well as the potential for novel effector biology,
but it is a difficult task as the secretome of B. pseudomallei
is very complex (Vander Broek et al., 2015). Also, due to the
temporal and hierarchical control of the T3SS, there is always
the possibility that an effector protein will not be secreted
under the conditions used in a given experiment (reviewed in
Büttner, 2012). Previous methods of identifying T3SS-3 effector
proteins have relied on initial bioinformatics prediction (Stevens
et al., 2003; Muangman et al., 2011) or high throughput screens
(Vander Broek et al., 2015), both of which may prove to be
useful tools for further studies of B. pseudomallei T3S. Indeed
it is timely to apply these approaches to the identification and
characterization of effector proteins secreted by the lesser studied
T3SS-1 and T3SS-2.
Another important outstanding area of research is
characterizing the functions of those effector proteins that
have already been identified. One common characteristic of
many T3SS effector proteins that complicates this task is their
functional redundancy (reviewed in Galán, 2009). Commonly,
deletion of one effector protein yields little or no phenotype in
infection models because other effector proteins target either
the same host cell protein or pathway (reviewed in Galán,
2009). In a biological system this would increase the chance of
effectors successfully carrying out their intended function and
decrease the likelihood of host cell interference. This functional
redundancy also highlights the evolutionary importance of
dysregulating specific cellular pathways from the standpoint
of the bacterium. Even where redundancy does not exist, the
function of effector proteins are often subtle when compared
to bacterial toxins and may not be easily measurable in in
vitro or in vivo models of infection (reviewed in Dean, 2011).
This lack of a phenotype to inform focused studies presents a
challenge for investigators, creating the need for high throughput
“fishing” assays, such as protein immunoprecipitation/pull-
downs and yeast two-hybrid assays. These assays have been
used successfully to identify host cell binding partners and
the subsequent functions of effector proteins from other
bacteria (Zhou et al., 2013; Pallett et al., 2014). Understanding
the functions of T3SS-3 effector proteins may provide new
insights into host-pathogen interactions in B. pseudomallei
infection.
Finally, the T3SS-3 has been shown to be one of the
most important virulence factors in B. pseudomallei models of
infection, raising the question of whether T3SS-3 could be a
useful target for protective vaccines or therapeutic intervention in
melioidosis patients. Although several attempts have been made
to use live-attenuated vaccines based on mutation of key T3SS-
3 genes in murine models of melioidosis, none have proven to
provide sterilizing immunity. Despite being a potent B- and T-
cell antigen, attempts to utilize BipD as a subunit vaccine in
murine models of melioidosis have shown little promise (Stevens
et al., 2004; Druar et al., 2008). There have also been attempts
to use the translocator proteins of T3SS-3 as subunit vaccines.
The N-terminal region of BipB was tested as a protective antigen
in mice, but showed no protection against subsequent challenge
(Druar et al., 2008). The C-terminal and N-terminal regions of
BipC have also been separately tested as a subunit vaccine in
mice, but neither antigen showed any protection (Druar et al.,
2008). Some studies have focused on the use of effector proteins
as subunit vaccines. Out of these studies the BopA protein
shows most promise, since mice immunized with recombinant
BopA were protected against subsequent intranasal challenge
with both B. mallei and B. pseudomallei (Whitlock et al., 2010).
More recently interest in the use of small molecule inhibitors
of the T3SS-3 has arisen (Gong et al., 2015). Treatment of B.
pseudomallei infected RAW264.7 cells with a small molecule
inhibitor targeting BsaS of the T3SS-3, resulted in a decrease
in bacterial intracellular survival (Gong et al., 2015). However,
the use of such inhibitors is still very much in its infancy, with
important in vivo studies being required to determine whether
such small molecules would be effective in murine models of
melioidosis.
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